An efficacy comparison of selected CD34− HSCs and unmanipulated HSCs in the improvement of SSc showed that CD34+ stem cells are more effective in the improvement of the mRSS and pulmonary function than unmanipulated ones. This evidence concerns the gene CD34 and systemic sclerosis.